Ergos receives $3 mn fresh investment to close $11 million fund raise

Published - January 13, 2021 10:13 pm IST - MUMBAI

Ergos, an agritech start-up, has received fresh investment of ₹22.5 crore ($3 million) from CDC of U.K. to close an ₹81 crore ($11 million) fund raise with participation from two other investors Aavishkaar Capital and Chiratae Ventures.

Ergos is building a GrainBank model which has been piloted in Bihar, it said.

This model enables farmers to digitise their food grain and also provides them doorstep access to end-to-end postharvest supply chain solutions by leveraging its technology platform, it added.

The platform operates like a bank and offers storage, digitisation, credit and liquidate facility to farmers and has been helping them achieve higher incomes for their produce, the firm said.

Kishor Jha, founder & CEO, Ergos said “We are building Ergos primarily to extend post-harvest support to small and marginal farmers on storage, credit and market linkages at farm-gate. We are leveraging technology to empower farmers and enable them to be key decision takers with respect to their crop produce.”

“We intend to rapidly scale our geographic footprint and remain steadfast in our desire to cater to millions of farmers directly at farm-gate over the next few years,” he said.

Craig Gifford, head of South Asia Private Equity Funds, CDC Group said, “Investing to support small holder farmers and improve their livelihoods is a strong demonstration of how we use our capital at CDC.”

“Leveraging cutting edge technology is key to addressing some of the challenges farmers face in India. Ergos is extremely well placed to make a meaningful difference to their lives, and we are delighted to co-invest alongside Aavishkaar Capital, a longstanding partner of CDC, to support an ambitious management in building their business,” he said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.